HCA Healthcare (HCA) EBITDA Margin (2010 - 2026)

HCA Healthcare has disclosed EBITDA Margin across 17 years of filings, most recently posting 2.96% for Q1 2026.

• In Q1 2026, EBITDA Margin rose 532.0% year-over-year to 2.96%; the TTM figure through Mar 2026 stood at 9.9% (down 101.0% YoY), while the FY2025 annual figure was 7.37%, up 17.0% from the prior year.
• EBITDA Margin rose to 2.96% in Q1 2026, from 24.72% in the prior quarter.
• Over the last five years, EBITDA Margin for HCA reached as high as 17.73% in Q4 2022 and fell as low as 25.84% in Q4 2024.
• The 5-year median for EBITDA Margin is 8.46% (2022), against an average of 1.1%.
• Annual changes were most pronounced in 2024 — EBITDA Margin slumped 3697 bps — and 2026, when it jumped 532 bps.
• A 5-year view of EBITDA Margin shows it stood at 17.73% in 2022, then tumbled by 37 bps to 11.14% in 2023, then tumbled by 332 bps to 25.84% in 2024, then gained by 4 bps to 24.72% in 2025, then surged by 88 bps to 2.96% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 2.96%, 24.72%, and 9.1% for Q1 2026, Q4 2025, and Q3 2025 respectively.